1. Home
  2. RDHL vs TWAV Comparison

RDHL vs TWAV Comparison

Compare RDHL & TWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

N/A

Current Price

$0.80

Market Cap

3.8M

Sector

Health Care

ML Signal

N/A

TWAV

TaoWeave Inc. Common Stock

N/A

Current Price

$1.72

Market Cap

4.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
RDHL
TWAV
Founded
2009
N/A
Country
Israel
United States
Employees
N/A
7
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
4.2M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
RDHL
TWAV
Price
$0.80
$1.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
22.5K
105.2K
Earning Date
05-01-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$381.91
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$0.58
52 Week High
$3.31
$2.41

Technical Indicators

Market Signals
Indicator
RDHL
TWAV
Relative Strength Index (RSI) 41.73 57.51
Support Level $0.79 $1.69
Resistance Level $0.89 $1.89
Average True Range (ATR) 0.05 0.18
MACD 0.01 -0.01
Stochastic Oscillator 51.31 56.14

Price Performance

Historical Comparison
RDHL
TWAV

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About TWAV TaoWeave Inc. Common Stock

TaoWeave Inc is a digital asset company. The company offers investors a regulated, publicly traded vehicle to gain exposure to the decentralized AI economy. The company aims to invest in the Bittensor ecosystem through partnerships with subnets, miners, and validators, amd operates with zero debt by maintain appropriate cash reserves.

Share on Social Networks: